HI
RYTM icon

Harbour Investments’s Rhythm Pharmaceuticals RYTM Stock Holding History

Harbour Investments’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.66K Hold
60
– – ﹤0.01% 3563
2026
Q1 		$5.22K Hold
60
– – ﹤0.01% 3582
2025
Q4 		$6.42K Buy
+60
New +$6.37K ﹤0.01% 2928
2023
Q2 		– Sell
-148
Closed -$2.64K – 3110
2023
Q1 		$2.64K Hold
148
– – ﹤0.01% 2485
2022
Q4 		$4.31K Buy
+148
New +$3.8K ﹤0.01% 2266

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Harbour Investments's RYTM Position: Q2 2026 in Review

Harbour Investments held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 60 shares worth $6.66K. The position accounts for ﹤0.01% of the portfolio, ranked #3563.

Harbour Investments first reported a position in RYTM in Q4 2022 and has held it in 5 quarters since. 305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Harbour Investments held 60 shares of Rhythm Pharmaceuticals worth $6.66K as of Q2 2026.
  • Harbour Investments left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3563 holding.
  • Harbour Investments first reported a position in Rhythm Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
  • 305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.